chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site movement impairment
Clinical narrative: Can not extend arm fully; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Can not extend arm fully) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Injury NOS (arm had screws).    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Can not extend arm fully). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Can not extend arm fully) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.  The vaccination was taken on the arm that had screws in due to a previous injury.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever / temperature was 101.1; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever / temperature was 101.1) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PYREXIA (Fever / temperature was 101.1). At the time of the report, PYREXIA (Fever / temperature was 101.1) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, Body temperature: 101.1 (High) 101.1.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment was not taken; enquired about treatment options.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: violent diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (violent diarrhea) in a 94-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 1042120A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIARRHOEA (violent diarrhea). At the time of the report, DIARRHOEA (violent diarrhea) had resolved.            The patient had loose stool for about 3 to 4 times.No concomitant medications reported.  No treatment medications provided by the reporter.   Action taken with mRNA-1273 in response to event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up information received on 21 Jun 2021.Updated outcome of event from unknown to resolved.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: (arm) hot; arm very very red; (arm) itching; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH ((arm) hot), VACCINATION SITE ERYTHEMA (arm very very red), VACCINATION SITE PRURITUS ((arm) itching) and HEADACHE (headache) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced HEADACHE (headache). On 07-Feb-2021, the patient experienced VACCINATION SITE WARMTH ((arm) hot), VACCINATION SITE ERYTHEMA (arm very very red) and VACCINATION SITE PRURITUS ((arm) itching). At the time of the report, VACCINATION SITE WARMTH ((arm) hot), VACCINATION SITE ERYTHEMA (arm very very red), VACCINATION SITE PRURITUS ((arm) itching) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was provided No treatment  information was provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypoaesthesia, Pruritus
Clinical narrative: itching sensation- all over body; my face felt numb; redness - of the face; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching sensation- all over body), HYPOAESTHESIA (my face felt numb) and ERYTHEMA (redness - of the face) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PRURITUS (itching sensation- all over body), HYPOAESTHESIA (my face felt numb) and ERYTHEMA (redness - of the face). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching all over, Numbness facial and Redness of face, at a dose of UNK dosage form. On 27-Jan-2021, PRURITUS (itching sensation- all over body), HYPOAESTHESIA (my face felt numb) and ERYTHEMA (redness - of the face) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  Treatment included Benadryl to alleviate the symptoms and symptoms seemed to go away by 27-Jan-2021.   Most recent FOLLOW-UP information incorporated above includes: On 01-Feb-2021: Reporter details, patient details, suspect product batch number, event verbatim updated.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash
Clinical narrative: Red rash at injection site; Red rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Red rash at injection site) and VACCINATION SITE ERYTHEMA (Red rash at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE RASH (Red rash at injection site) and VACCINATION SITE ERYTHEMA (Red rash at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site rash and Vaccination site erythema, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE RASH (Red rash at injection site) and VACCINATION SITE ERYTHEMA (Red rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: was itchy; rash  at injection sight; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash  at injection sight) and VACCINATION SITE PRURITUS (was itchy) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE RASH (rash  at injection sight) and VACCINATION SITE PRURITUS (was itchy). The patient was treated with HYDROCORTISONE for Vaccination site pruritus, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (rash  at injection sight) and VACCINATION SITE PRURITUS (was itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No concomitant medications reported .  At the time of report, rash was bigger.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.            No concomitant medications reported. No treatment medications provided by the reporter.  Action taken with mRNA-1273 in response to event was not applicable.    This case was linked to MOD-2021-024115 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: had difficulty breathing; Raised area at injection site; Redness at injection site; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (had difficulty breathing), VACCINATION SITE SWELLING (Raised area at injection site), VACCINATION SITE PRURITUS (Redness at injection site) and VACCINATION SITE PAIN (Pain at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced DYSPNOEA (had difficulty breathing), VACCINATION SITE SWELLING (Raised area at injection site), VACCINATION SITE PRURITUS (Redness at injection site) and VACCINATION SITE PAIN (Pain at injection site). At the time of the report, DYSPNOEA (had difficulty breathing), VACCINATION SITE SWELLING (Raised area at injection site), VACCINATION SITE PRURITUS (Redness at injection site) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included unknown.   Reporter did not allow further contact
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site hypoaesthesia
Clinical narrative: numbness on the right arm where she was vaccinated; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPOAESTHESIA (numbness on the right arm where she was vaccinated) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE HYPOAESTHESIA (numbness on the right arm where she was vaccinated). The patient was treated with FUROSEMIDE (LASIX [FUROSEMIDE]) on 01-Feb-2021 for Vaccination site hypoaesthesia, at a dose of UNK dosage form. On 01-Feb-2021, VACCINATION SITE HYPOAESTHESIA (numbness on the right arm where she was vaccinated) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was reported as Lasix.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Skin warm, Vaccination site rash
Clinical narrative: arm swelled up; arm turned red; arm was hot; arm itched on and off; Injection site still 3-4-inch mark; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelled up), ERYTHEMA (arm turned red), SKIN WARM (arm was hot), PRURITUS (arm itched on and off) and VACCINATION SITE RASH (Injection site still 3-4-inch mark) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol, Penicillin allergy, Drug allergy (atorvastatin, cefdinir, diclofenac, meloxicam, zoster vaccine, amoxicillin, Biaxin, codeine, penicillin, Levaquin, levofloxacin, doxycycline, nitrofurantoin and carisoprodol), Allergy to antibiotic and Allergy to vaccine.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PERIPHERAL SWELLING (arm swelled up), ERYTHEMA (arm turned red), SKIN WARM (arm was hot), PRURITUS (arm itched on and off) and VACCINATION SITE RASH (Injection site still 3-4-inch mark). At the time of the report, PERIPHERAL SWELLING (arm swelled up), ERYTHEMA (arm turned red), SKIN WARM (arm was hot), PRURITUS (arm itched on and off) and VACCINATION SITE RASH (Injection site still 3-4-inch mark) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Nausea
Clinical narrative: Migraine; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine) and NAUSEA (Nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012620A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced MIGRAINE (Migraine) and NAUSEA (Nausea). At the time of the report, MIGRAINE (Migraine) and NAUSEA (Nausea) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Headache
Clinical narrative: Pressure in the head; Headache; Any change in the body elevation makes the headache worse; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021.    This spontaneous case was reported by a nurse and describes the occurrence of HEAD DISCOMFORT (Pressure in the head), HEADACHE (Headache) and HEADACHE (Any change in the body elevation makes the headache worse) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 011320A) for COVID-19 vaccination.     Concurrent medical conditions included Pre-diabetes.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced HEAD DISCOMFORT (Pressure in the head), HEADACHE (Headache) and HEADACHE (Any change in the body elevation makes the headache worse). At the time of the report, HEAD DISCOMFORT (Pressure in the head), HEADACHE (Headache) and HEADACHE (Any change in the body elevation makes the headache worse) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.Concomitant medication includes  pre diabetes medication
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Contusion, Petechiae
Clinical narrative: Petechiae; blister with blood underneath behind her knee; bruiseon abdomen and right arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Feb-2021 and was forwarded to Moderna on 26-Feb-2021.    This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PETECHIAE (Petechiae), BLISTER (blister with blood underneath behind her knee) and CONTUSION (bruiseon abdomen and right arm) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20a and 012l20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PETECHIAE (Petechiae), BLISTER (blister with blood underneath behind her knee) and CONTUSION (bruiseon abdomen and right arm). At the time of the report, PETECHIAE (Petechiae), BLISTER (blister with blood underneath behind her knee) and CONTUSION (bruiseon abdomen and right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication  was not provided. Treatment information was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain, Pain in extremity
Clinical narrative: Body ache; Aches in the leg; Aches in the arm; Headache; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), PAIN IN EXTREMITY (Aches in the leg), PAIN IN EXTREMITY (Aches in the arm), HEADACHE (Headache) and FATIGUE (Fatigue) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN (Body ache), PAIN IN EXTREMITY (Aches in the leg), PAIN IN EXTREMITY (Aches in the arm), HEADACHE (Headache), FATIGUE (Fatigue) and NAUSEA (Nausea). At the time of the report, PAIN (Body ache), PAIN IN EXTREMITY (Aches in the leg), PAIN IN EXTREMITY (Aches in the arm), HEADACHE (Headache), FATIGUE (Fatigue) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient is taking other medication. No treatment information was provided. No relevant concomitant medications reported.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation
Clinical narrative: disorientated; This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (disorientated) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.  Previously administered products included for an unreported indication: ASPIRIN (E.C.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DISORIENTATION (disorientated). At the time of the report, DISORIENTATION (disorientated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. Concomitant information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Additional information include no new information.
Sex: M
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: cough; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (cough). At the time of the report, COUGH (cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Concomitant information was not provided.   This case was linked to MOD-2021-024260 (E2B Linked Report).; Sender's Comments:  MOD-2021-024260:same reporter, different patient and event
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: both arms are numb - feels like they have gone to sleep; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (both arms are numb - feels like they have gone to sleep) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concomitant products included INSULIN DETEMIR (LEVEMIR), INSULIN ASPART (NOVOLOG), RAMIPRIL, CARVEDILOL, CELECOXIB (CELEBREX), ESTROGENS CONJUGATED (PREMARIN), AMITRIPTYLINE, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), POTASSIUM CHLORIDE, ACETYLSALICYLIC ACID (BABY ASPIRIN), LEVOTHYROXINE SODIUM (SYNTHROID), DULOXETINE HYDROCHLORIDE (CYMBALTA), ATORVASTATIN CALCIUM (LIPITOR), DICYCLOMINE HCL, HYDROCHLOROTHIAZIDE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and METFORMIN for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced HYPOAESTHESIA (both arms are numb - feels like they have gone to sleep). At the time of the report, HYPOAESTHESIA (both arms are numb - feels like they have gone to sleep) outcome was unknown. Possible          No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Psychotic disorder
Clinical narrative: feel lousy/feeling worse/I don't feel good physically; feeling psychotic; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feel lousy/feeling worse/I don't feel good physically) and PSYCHOTIC DISORDER (feeling psychotic) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (feel lousy/feeling worse/I don't feel good physically) and PSYCHOTIC DISORDER (feeling psychotic). At the time of the report, MALAISE (feel lousy/feeling worse/I don't feel good physically) outcome was unknown and PSYCHOTIC DISORDER (feeling psychotic) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. concomitant information was not provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rashes on the right hand; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (rashes on the right hand) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced RASH (rashes on the right hand). At the time of the report, RASH (rashes on the right hand) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. concomitant information was not provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Dysphonia, Fatigue
Clinical narrative: Weird Voice; Vomited; Headache; Very Tired; Dizzy; Feels Sick; Runny nose; Joint pains; Body aches and pains; The chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Feels Sick), RHINORRHOEA (Runny nose), DIZZINESS (Dizzy), DYSPHONIA (Weird Voice) and ARTHRALGIA (Joint pains) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PACLITAXEL (PAXEL), RIFABUTIN (RIBUTIN) and ATORVASTATIN for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced ILLNESS (Feels Sick), RHINORRHOEA (Runny nose), ARTHRALGIA (Joint pains), MYALGIA (Body aches and pains) and CHILLS (The chills). On 23-Feb-2021, the patient experienced DIZZINESS (Dizzy). 23-Feb-2021, the patient experienced VOMITING (Vomited), HEADACHE (Headache) and FATIGUE (Very Tired). On 24-Feb-2021, the patient experienced DYSPHONIA (Weird Voice). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (Feels Sick), RHINORRHOEA (Runny nose), DIZZINESS (Dizzy), DYSPHONIA (Weird Voice), ARTHRALGIA (Joint pains), MYALGIA (Body aches and pains), CHILLS (The chills), VOMITING (Vomited), HEADACHE (Headache) and FATIGUE (Very Tired) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Non-Significant Follow-up received on 14-July-2021 and contains updated reporter contact information
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Illness, Myalgia, Rhinorrhoea, Vomiting
Clinical narrative: Weird Voice; Vomited; Headache; Very Tired; Dizzy; Feels Sick; Runny nose; Joint pains; Body aches and pains; The chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Feels Sick), RHINORRHOEA (Runny nose), DIZZINESS (Dizzy), DYSPHONIA (Weird Voice) and ARTHRALGIA (Joint pains) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PACLITAXEL (PAXEL), RIFABUTIN (RIBUTIN) and ATORVASTATIN for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced ILLNESS (Feels Sick), RHINORRHOEA (Runny nose), ARTHRALGIA (Joint pains), MYALGIA (Body aches and pains) and CHILLS (The chills). On 23-Feb-2021, the patient experienced DIZZINESS (Dizzy). 23-Feb-2021, the patient experienced VOMITING (Vomited), HEADACHE (Headache) and FATIGUE (Very Tired). On 24-Feb-2021, the patient experienced DYSPHONIA (Weird Voice). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (Feels Sick), RHINORRHOEA (Runny nose), DIZZINESS (Dizzy), DYSPHONIA (Weird Voice), ARTHRALGIA (Joint pains), MYALGIA (Body aches and pains), CHILLS (The chills), VOMITING (Vomited), HEADACHE (Headache) and FATIGUE (Very Tired) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Non-Significant Follow-up received on 14-July-2021 and contains updated reporter contact information
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Excessive cerumen production, Fatigue, Feeling abnormal, Headache
Clinical narrative: not normal ear wax   "large amount of gunk" was removed from her ear; clogged ear sensation; hearing diminished; truble lifiting arm; horrible headache; Tiredness; I had audio high pitch sound; Vaccination site pain; Felt like medication was coming out of arm; This spontaneous case was reported by a consumer and describes the occurrence of EXCESSIVE CERUMEN PRODUCTION (not normal ear wax   "large amount of gunk" was removed from her ear), TINNITUS (I had audio high pitch sound), VACCINATION SITE PAIN (Vaccination site pain), FEELING ABNORMAL (Felt like medication was coming out of arm) and EAR DISCOMFORT (clogged ear sensation) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Feb-2021 at 10:45 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced TINNITUS (I had audio high pitch sound), VACCINATION SITE PAIN (Vaccination site pain), FEELING ABNORMAL (Felt like medication was coming out of arm), LIMB DISCOMFORT (truble lifiting arm), HEADACHE (horrible headache) and FATIGUE (Tiredness). On an unknown date, the patient experienced EXCESSIVE CERUMEN PRODUCTION (not normal ear wax   "large amount of gunk" was removed from her ear), EAR DISCOMFORT (clogged ear sensation) and HYPOACUSIS (hearing diminished). At the time of the report, EXCESSIVE CERUMEN PRODUCTION (not normal ear wax   "large amount of gunk" was removed from her ear), TINNITUS (I had audio high pitch sound), FEELING ABNORMAL (Felt like medication was coming out of arm), EAR DISCOMFORT (clogged ear sensation), HYPOACUSIS (hearing diminished), LIMB DISCOMFORT (truble lifiting arm), HEADACHE (horrible headache) and FATIGUE (Tiredness) outcome was unknown and VACCINATION SITE PAIN (Vaccination site pain) had not resolved.            No concomitant medications were provided.  No treatment medications were provided.  Patient had a similar side effect after receiving both doses of the Moderna COVID-19 vaccine.   This case was linked to MOD21-123712 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: patient demographics updated: initials, date of birth & age. On 26-Jul-2021: events updated- chunk of gunk, clogged ear, not normal wax, hearing diminished
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoacusis, Limb discomfort, Tinnitus, Vaccination site pain
Clinical narrative: not normal ear wax   "large amount of gunk" was removed from her ear; clogged ear sensation; hearing diminished; truble lifiting arm; horrible headache; Tiredness; I had audio high pitch sound; Vaccination site pain; Felt like medication was coming out of arm; This spontaneous case was reported by a consumer and describes the occurrence of EXCESSIVE CERUMEN PRODUCTION (not normal ear wax   "large amount of gunk" was removed from her ear), TINNITUS (I had audio high pitch sound), VACCINATION SITE PAIN (Vaccination site pain), FEELING ABNORMAL (Felt like medication was coming out of arm) and EAR DISCOMFORT (clogged ear sensation) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Feb-2021 at 10:45 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced TINNITUS (I had audio high pitch sound), VACCINATION SITE PAIN (Vaccination site pain), FEELING ABNORMAL (Felt like medication was coming out of arm), LIMB DISCOMFORT (truble lifiting arm), HEADACHE (horrible headache) and FATIGUE (Tiredness). On an unknown date, the patient experienced EXCESSIVE CERUMEN PRODUCTION (not normal ear wax   "large amount of gunk" was removed from her ear), EAR DISCOMFORT (clogged ear sensation) and HYPOACUSIS (hearing diminished). At the time of the report, EXCESSIVE CERUMEN PRODUCTION (not normal ear wax   "large amount of gunk" was removed from her ear), TINNITUS (I had audio high pitch sound), FEELING ABNORMAL (Felt like medication was coming out of arm), EAR DISCOMFORT (clogged ear sensation), HYPOACUSIS (hearing diminished), LIMB DISCOMFORT (truble lifiting arm), HEADACHE (horrible headache) and FATIGUE (Tiredness) outcome was unknown and VACCINATION SITE PAIN (Vaccination site pain) had not resolved.            No concomitant medications were provided.  No treatment medications were provided.  Patient had a similar side effect after receiving both doses of the Moderna COVID-19 vaccine.   This case was linked to MOD21-123712 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: patient demographics updated: initials, date of birth & age. On 26-Jul-2021: events updated- chunk of gunk, clogged ear, not normal wax, hearing diminished
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Pain, Sciatica
Clinical narrative: sciatica; very painful going from back to the ankle; couldn't do anything for 2 weeks because of the pain; A spontaneous report was received from a consumer article concerning a 78 years old, female  patient who developed/experienced Sciatica,very painful going from back to the ankle,couldn't do anything for 2 weeks because of the pain.  The patient medical history was not provided.Concomitant product use was not provided/unknown by the reporter.  On 27-JAN-2021,prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number:032L2OA intramuscularly in the unknown site for prophylaxis of COVID-19 infection On 24-FEB-2021,prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 (Batch number:023M20A intramuscularly in the unknown site for prophylaxis of COVID-19 infection.  On 27-JAN-2021,the patient experienced the events Sciatica,very painful going from back to the ankle,couldn't do anything for 2 weeks because of the pain.  Treatment information included Advil and aspercreme with 4% lidocaine in it  Action taken with mRNA with response to events was not provided.  On an unknown date,sciatica,very painful going from back to the ankle ,couldn't do anything for 2 weeks because of the pain was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Pyrexia, Urticaria
Clinical narrative: for 48 hr high fever; for 48 hr chills.; very red hives (2 by 3 inches) it burns; very red hives (2 by 3 inches) it burns; A spontaneous report was received from a healthcare professional concerning a Drug Start Date-1947-1-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events for 48 hr high fever and chills, very red hives (2 by 3 inches) and it burns.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 0X8L20A) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events for 48 hr high fever and chills, very red hives (2 by 3 inches) and it burns.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events for 48 hr high fever and chills, very red hives (2 by 3 inches) and it burns were unknown.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Pyrexia
Clinical narrative: Fatigue; Arm pain; Fever - Temperature of 100.4F; Arm pain; A spontaneous report was received from a Consumer concerning her husband  67 Years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events Fatigue,Injection site pain and Pyrexia.    The patient's medical history was not provided. No relevant concomitant medications were reported.    On 16-Jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch:unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 13-Feb-2021, the patient received second of two planned doses of mRNA-1273 (lot/batch:unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 17-Jan-2021, The patient experienced the event arm pain and on 14-Feb-2021 the patient experienced the events Fatigue,Injection site pain and Fever - Temperature of 100.4F.     Laboratory details was not  provided.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   On 17-JAN-2021, the outcome of the event Arm pain was recoverd/resolved and on 14-FEB-2021 the outcome of the events Fatigue was recoverd/resolved,Injection site pain was recoverd/resolved and Fever - Temperature of 100.4F was recoverd/resolved    The reporter assessed the events arm pain, Fatigue,Injection site pain and Fever - Temperature of 100.4F related to study drug is unknown.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Erythema, Paraesthesia, Peripheral swelling
Clinical narrative: Red arm; Swollen arm; Arm angry and hot; Feeling Uncomfortable; A spontaneous report was received from an 82-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced red arm/erythema,swollen arm/peripheral swelling, angry,hot arm/ paraesthesia and feeling uncomfortable / discomfort.  The patient's medical history was not provided Concomitant product use was not provided/unknown by the reporter.  On 9 Jan 2021, prior to the onset of the events ,the patient received their first of two planned doses of mRNA-1273 (lot/batch: 011L20A)via unknown route  in the left arm for prophylaxis of COVID-19 infection.  On 17 Jan 2021, the patient experienced red ,swollen ,angry and hot arm and were feeling uncomfortable. Treatment included ice and cool damp rag.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of event ,swollen,hot arm and feeling uncomfortable were considered to be resolving.The outcome of the event, red arm was considered to be resolved.
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: having a very bad experience; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events having a very bad experience.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unk) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) having a very bad experience.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), having a very bad experience was unknown.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea
Clinical narrative: Chills; diarrhea, it's like brown water; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea, it's like brown water) and CHILLS (Chills) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced DIARRHOEA (diarrhea, it's like brown water). On 03-Feb-2021, the patient experienced CHILLS (Chills). On 03-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, DIARRHOEA (diarrhea, it's like brown water) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details were not provided.  Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness in arm; A spontaneous report was received from a consumer concerning a 67-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events soreness in arm/pain in extremity.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection. No adverse events reported to the first dose of the vaccine.   On 24 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 013M20A) intramuscularly for prophylaxis of COVID-19 infection.  On 24 Feb 2021, the patient experienced the event soreness in arm following administration of vaccine.  No treatment information was provided.  Since patient received both the scheduled doses of the vaccine action taken with mRNA-1273 in response to the events was not applicable.  The outcome of event soreness in arm was not resolved.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Myalgia
Clinical narrative: Dry cough; Headache; Fatigue; Body ache; A spontaneous report was received from a consumer concerning a 70-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events headache, fatigue, body ache and dry cough.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 24 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route in left arm for prophylaxis of COVID-19 infection.  On 25 Feb 2021, the patient experienced the events headache, fatigue, body ache and dry cough.  No treatment was taken by the patient.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events headache, fatigue, body ache and dry cough was not resolved.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Pain, Pyrexia
Clinical narrative: Coughing; Body Aches; Fever; Chills; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing), PAIN (Body Aches), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headaches) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03IL20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient was diagnosed in last December with COVID) in December 2020. Concomitant products included SIMVASTATIN and LEVOTHYROXINE for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (Coughing), PAIN (Body Aches), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headaches). At the time of the report, COUGH (Coughing), PAIN (Body Aches), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Vaccination site erythema
Clinical narrative: Diarrhea; Tiredness; Redness around injection site; This spontaneous case was reported by a nurse and describes the occurrence of DIARRHOEA (Diarrhea), FATIGUE (Tiredness) and VACCINATION SITE ERYTHEMA (Redness around injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), FATIGUE (Tiredness) and VACCINATION SITE ERYTHEMA (Redness around injection site). On 23-Jan-2021, DIARRHOEA (Diarrhea) and FATIGUE (Tiredness) had resolved. On 28-Jan-2021, VACCINATION SITE ERYTHEMA (Redness around injection site) had resolved. Possible      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.